Discrepancy between mRNA and protein expression of neutrophil gelatinase-associated lipocalin in bronchial epithelium induced by sulfur mustard

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Ebrahimi, Majid ^a   Roudkenar, Mehryar Habibi ^b   Imani Fooladi, Abbas Ali ^a   Halabian, Raheleh ^b   Ghanei, Mostafa ^a   Kondo, Hisatake ^c   Nourani, Mohammad Reza ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c TOHOKU BUNKA GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MUSTARD GAS; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHUS MUCOSA; CELL PROTECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG BIOPSY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN VARIANT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXIC INHALATION; UPREGULATION;

EID: 77953493179     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/823131     Document Type: Article

References (44)

1. Marrs T. C., Maynard R. L., Sidell F. R., Mustard gas Chamical Warfare Agents, Toxicology and Treatment 1996 chapter 6 London, UK Jahn Wiley Sons 139 173
2. United Nations Security Council, Report of the Mission Dispatched by the Secretary General to Investigate Allegations of the Use of Chemical Weapons in the Conflict between the Islamic Republic of Iran and Iraq. S/19823 1988 New York, NY, USA United Nations
3. Khateri S., Ghanei M., Keshavarz S., Soroush M., Haines D., Incidence of lung, eye, and skin lesions as late complications in 34000 Iranians with wartime exposure to mustard agent Journal of Occupational and Environmental Medicine 2003 45 11 1136 1143
4. Ghanei M., Aslani J., Khateri S., Hamadanizadeh K., Public health status of the civil population of Sardasht 15 years following large-scale war time exposure to sulfur mustard Journal of Burns and Surgical Wound Care 2003 2 1 7
5. Thomason J. W. W., Rice T. W., Milstone A. P., Bronchiolitis obliterans in a survivor of a chemical weapons attack Journal of the American Medical Association 2003 290 5 598 599
6. Ghanei M., Mokhtari M., Mohammad M. M., Aslani J., Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography European Journal of Radiology 2004 52 2 164 169
7. Laohaburanakit P., Chan A., Allen R. P., Bronchiolitis obliterans Clinical Reviews in Allergy and Immunology 2003 25 3 259 274
8. Estenne M., Maurer J. R., Boehler A., Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria Journal of Heart and Lung Transplantation 2002 21 3 297 310
9. Chang A. B., Masel J. P., Masters B., Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae Pediatric Radiology 1998 28 1 23 29
10. Boehler A., Vogt P., Speich R., Weder W., Russi E. W., Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine European Respiratory Journal 1996 9 6 1317 1319
11. Markopoulou K. D., Cool C. D., Elliot T. L., Obliterative bronchiolitis: varying presentations and clinicopathological correlation European Respiratory Journal 2002 19 1 20 30
12. Ghanei M., Ghayumi M., Ahakzani N., Noninvasive diagnosis of bronchiolitis obliterans due to sulfur mustard exposure: could high-resolution computed tomography give us a clue? Radiologia Medica 2010 115 413 420
13. Ghanei M., Tazelaar H. D., Chilosi M., An International collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients Respiratory Medicine 2008 102 6 825 830
14. Ghanei M., Shohrati M., Jafari M., Ghaderi S., Alaeddini F., Aslani J., N-acetylcysteine improves the clinical conditions of mustard gas-exposed patients with normal pulmonary function test Basic and Clinical Pharmacology Toxicology 2008 103 5 428 432
15. Toews G. B., Impact of bacterial infections on airway diseases European Respiratory Review 2005 14 95 62 68
16. Johnston S. L., Impact of viruses on airway diseases European Respiratory Review 2005 14 95 57 61
17. Greene L. S., Asthma, oxidant stress, and diet Nutrition 1999 15 11-12 899 907
18. Rahman I., Adcock I. M., Oxidative stress and redox regulation of lung inflammation in COPD European Respiratory Journal 2006 28 1 219 242
19. Madill J., Aghdassi E., Arendt B., Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome? Transplantation Reviews 2009 23 2 103 110
20. Flower D. R., North A. C. T., Sansom C. E., The lipocalin protein family: structural and sequence overview Biochimica et Biophysica Acta 2000 1482 1-2 9 24
21. Kjeldsen L., Johnsen A. H., Sengelov H., Borregaard N., Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase Journal of Biological Chemistry 1993 268 14 10425 10432
22. Triebel S., Blaser J., Reinke H., Tschesche H., A 25 kDa 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase FEBS Letters 1992 314 3 386 388
23. Chu S.-T., Lin H.-J., Huang H.-L., Chen Y.-H., The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins Journal of Peptide Research 1998 52 5 390 397
24. Devireddy L. R., Teodoro J. G., Richard F. A., Green M. R., Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation Science 2001 293 5531 829 834
25. Goetz D. H., Holmes M. A., Borregaard N., Bluhm M. E., Raymond K. N., Strong R. K., The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition Molecular Cell 2002 10 5 1033 1043
26. Nielsen B. S., Borregaard N., Bundgaard J. R., Timshel S., Sehested M., Kjeldsen L., Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases Gut 1996 38 3 414 420
27. Roudkenar M. H., Kuwahara Y., Baba T., Oxidative stress induced lipocalin 2 gene expression: addressing its expression under the harmful conditions Journal of Radiation Research 2007 48 1 39 44
28. Roudkenar M. H., Halabian R., Ghasemipour Z., Neutrophil gelatinase-associated lipocalin acts as a protective factor against H 2 O 2 toxicity Archives of Medical Research 2008 39 6 560 566 (Pubitemid 352033610)
29. Nourani M. R., Owada Y., Kitanaka N., Localization of epidermal-type fatty acid binding protein in macrophages in advanced atretic follicles of adult mice Journal of Molecular Histology 2005 36 6-7 391 400
30. Ryon J., Bendickson L., Nilsen-Hamilton M., High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein Biochemical Journal 2002 367 1 271 277
31. Tong Z., Wu X., Ovcharenko D., Zhu J., Chen C.-S., Kehrer J. P., Neutrophil gelatinase-associated lipocalin as a survival factor Biochemical Journal 2005 391 2 441 448
32. Lee H.-J., Lee E.-K., Lee K.-J., Hong S.-W., Yoon Y., Kim J.-S., Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells International Journal of Cancer 2006 118 10 2490 2497
33. Han S., Espinoza L. A., Liao H., Boulares A. H., Smulson M. E., Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes British Journal of Pharmacology 2004 141 5 795 802
34. Korkmaz A., Yaren H., Topal T., Oter S., Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation Archives of Toxicology 2006 80 10 662 670
35. Naghii M. R., Sulfur mustard intoxication, oxidative stress, and antioxidants Military Medicine 2002 167 7 573 575
36. Langen R. C. J., Korn S. H., Wouters E. F. M., ROS in the local and systemic pathogenesis of COPD Free Radical Biology and Medicine 2003 35 3 226 235
37. Rahman I., MacNee W., Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease Thorax 1996 51 4 348 350
38. Husain K., Dube S. N., Sugendran K., Singh R., Das Gupta S., Somani S. M., Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats Journal of Applied Toxicology 1996 16 3 245 248
39. Keatings V. M., Barnes P. J., Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects American Journal of Respiratory and Critical Care Medicine 1997 155 2 449 453
40. Eichler I., Nilsson M., Rath R., Enander I., Venge P., Koller D. Y., Human neutrophil lipocalin, a highly specific marker for acute exacerbation in cystic fibrosis European Respiratory Journal 1999 14 5 1145 1149
41. Betsuyaku T., Nishimura M., Takeyabu K., Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema American Journal of Respiratory and Critical Care Medicine 1999 159 6 1985 1991
42. Senior R. M., Shapiro S. D., Chronic obstructive pulmonary disease: epidemiology, pathophysiology, and pathogenesis Fishman's Pulmonary Diseases and Disorders 1997 3rd New York, NY, USA McGraw-Hill 659 681
43. Borregaard N., Cowland J. B., Granules of the human neutrophilic polymorphonuclear leukocyte Blood 1997 89 10 3503 3521
44. Shohrati M., Aslani J., Eshraghi M., Alaedini F., Ghanei M., Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test Respiratory Medicine 2008 102 3 443 448